000 01470 a2200397 4500
005 20250515212000.0
264 0 _c20100824
008 201008s 0 0 eng d
022 _a1873-5835
024 7 _a10.1016/j.leukres.2010.01.024
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBelada, David
245 0 0 _aDiffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: Successful treatment with risk-adapted rituximab-based immunochemotherapy.
_h[electronic resource]
260 _bLeukemia research
_cSep 2010
300 _ae232-4 p.
_bdigital
500 _aPublication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Murine-Derived
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCombined Modality Therapy
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aJob Syndrome
_xcomplications
650 0 4 _aLymphoma, Large B-Cell, Diffuse
_xcomplications
650 0 4 _aMale
650 0 4 _aRituximab
650 0 4 _aTomography, X-Ray Computed
650 0 4 _aTreatment Outcome
700 1 _aSmolej, Lukás
700 1 _aStepánková, Pavla
700 1 _aKrálícková, Pavlína
700 1 _aFreiberger, Tomás
773 0 _tLeukemia research
_gvol. 34
_gno. 9
_gp. e232-4
856 4 0 _uhttps://doi.org/10.1016/j.leukres.2010.01.024
_zAvailable from publisher's website
999 _c19592723
_d19592723